Eli Lilly Drops on Weight Loss Results; Fortinet Tumbles; Airbnb Lower
On this episode of Stock Movers:- Eli Lilly (LLY) is lower on news its experimental pill helped patients shed roughly 11% of their body weight in a late-stage study. The result falls on the lower end of Wall Street's expectations, as investors had hoped the pill would be as effective as Novo Nordisk A/S's Wegovy. Full year revenue did come in higher in Eli Lilly's earnings today as well.- Novo Nordisk (NVO) shares are rising on the Eli Lilly news. Investors had hoped Lilly’s pill, called orforglipron, would be as effective as Wegovy — the blockbuster weight-loss shot made by Novo…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.